You are here: All Products  > Gracell Reports 100% Minimal Residual Disease Rate for CAR-T in Myeloma Trial

Gracell Reports 100% Minimal Residual Disease Rate for CAR-T in Myeloma Trial

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products